JB Chemicals & Pharmaceuticals Q1 Results FY26: Q1 PAT Rose 14.45% to ₹202.38 Crore; Revenue Surged 8.91% YoY
Posted by : sachet | Thu Jul 31 2025

JB Chemicals & Pharmaceuticals Q1 Results FY26: JB Chemicals & Pharmaceuticals posted its Q1 results on 30th July 2025. The company posted robust numbers, with Q1 PAT standing at ₹202.38 crores against revenue of ₹1,093.94 crores. During Q1 FY26, the profit increase of the company was recorded at 14.45% YoY, and the revenue increase for the same period was 8.91%.
JB Chemicals & Pharmaceuticals Q1 Results FY26: Extracts of FY25 & FY26 (Consolidated Figures)
Particulars | Quarter Ended | |
30-06-2025 | 30-06-2024 | |
Revenue from Operations | ₹1,093.94 | ₹1,004.40 |
Profit Before Tax (PBT) | ₹315.42 | ₹286.26 |
Profit After Tax (PAT) | ₹202.38 | ₹176.83 |
(Figures in crores)
JB Chemicals & Pharmaceuticals Q1 Results FY26: Extracts of FY25 & FY26 (Standalone Figures)
Particulars | Quarter Ended | |
30-06-2025 | 30-06-2024 | |
Revenue from Operations | ₹1,039.90 | ₹952.31 |
Profit Before Tax (PBT) | ₹307.02 | ₹278.54 |
Profit After Tax (PAT) | ₹197.87 | ₹173.23 |
(Figures in crores)
JB Chemicals & Pharmaceuticals Results FY26 Highlights (Q1 FY26 vs FY25)
- JB Chemicals & Pharmaceuticals clocked Q1 FY26 consolidated revenue of ₹1,093.94 crores vs ₹1,004.40 crores.
- On the profit front, JB Chemicals & Pharmaceuticals earned a consolidated PAT of ₹202.38 crore in Q1 FY26. During FY25, the company’s PAT stood at ₹176.83 crore.
- Consolidated PAT rose for the first quarter of FY26, was 14.45% YoY, and revenue rose 8.91% YoY.
- As per the standalone figures, the quarterly PAT of JB Chemicals & Pharmaceuticals has increased by 14.22%, and revenue has increased by 9.20% YoY.
JB Chemicals & Pharmaceuticals Share Price Performance
On the opening bell of 31st July 2025, the shares of JB Chemicals & Pharmaceuticals opened at ₹1768.90 per share. However, the initial gains are wiped out as of now, and JB Chemicals & Pharmaceuticals shares are trading at ₹1765.10 per share, lower than their opening price.
Considering the long-term performance, JB Chemicals & Pharmaceuticals shares have yielded returns of approximately 9.29% over the past year, and 5-year returns stand at 384.99%. Over the maximum timeframe, the JB Chemicals & Pharmaceuticals share provided investors with returns of 4,390.18 %. However, one must ignore the risk of volatility in the stock market and invest in JB Chemicals & Pharmaceuticals shares after thorough research.
For regular stock updates, dividend alerts, and expert verdicts, stay informed with Univest!
Disclaimer: Investment in the share market is subject to risk. This news article is for informational purposes only. Conduct your own research before investing in shares and other securities.
Also Read : Shriram Finance Q1 Results FY26: Q1 PAT Rose 6.75% to ₹2,159.4 Crore; Revenue Surged 20.11% YoY
Recent Articles
Flysbs Aviation IPO GMP & Review: Apply or Avoid?
Sri Lotus Developers IPO GMP: Day 1 IPO Live Updates
Varun Beverages Q1 Results FY26: Q1 PAT Surged 5.14% to ₹1,317.02 Crore; Revenue Dropped 2.33% YoY
Takyon Networks IPO GMP: Day 1 IPO Live Updates
Asian Paints Q1 Results FY26: Q1 PAT Plunged 6.00% to ₹1,099.77 Crore; Revenue Dropped 0.35% YoY

Related Posts
Adani Enterprises Q1 Results FY26: Q1 PAT Plunged -49.51% to ₹734.41 Crore; Revenue Surged -13.78% YoY
IGL Q1 Results FY26: Q1 PAT Falls 10.84% to ₹429.05 Crore; Revenue Surged 11.30% YoY
Hitachi Energy India Q1 Results FY26: Q1 PAT Rose 1162.96% to ₹131.60 Crore; Revenue Surged 11.43% YoY
Mahindra & Mahindra Q1 Results FY26: Q1 PAT Rose 24.39% to ₹4,083.32 Crore; Revenue Surged 22.33% YoY
Hyundai Motor Q1 Results FY26: Q1 PAT Falls 8.08% to ₹1,369.23 Crore; Revenue Declined 5.37% YoY
Sun Pharmaceuticals Q1 Results FY26: Q1 PAT Rose -19.64% to ₹2,278.63 Crore; Revenue Surged 9.47% YoY